Company intelligence / Profile preview

Tiefenbacher

Hamburg, Germany

Ownership: Private
Employees: ~800
Development stage: Other

Overview

Tiefenbacher develops, manufactures, and commercializes >180 pharmaceutical products, including highly potent drugs and drug-device combinations, serving over 500 million patients yearly in 80+ countries. The company focuses on generics, value-added medicines, and innovative products, but does not disclose clinical trial results as it primarily operates as a developer and supplier to partners worldwide.[2][3][6]

Therapeutic areas: ImmunologyNephrologyMetabolic DisordersOphthalmologyInfectious DiseasesGastroenterologyPulmonologyDermatologyCardiovascularOncologyNeurology
Modalities: Small moleculeBiologicDrug medical device combination
Industry: Pharma

Partnerships

Multiple global marketing, distribution, and license partners (>150 customers on five continents)[2][3]

Beyond the preview

Go deeper on Tiefenbacher.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiefenbacher.

Explore the full profile